The ExoDx Prostate(IntelliScore) check analyzes urine exosomes to supply a danger evaluation for high-grade prostate most cancers. This genomic check helps clinicians decide whether or not a affected person presenting for an preliminary prostate biopsy is at excessive danger for aggressive illness. A damaging check end result might enable some sufferers to securely keep away from an preliminary biopsy. A constructive check end result can present extra data to assist a biopsy determination and information additional administration.
This non-invasive method gives a major development in prostate most cancers diagnostics. It helps cut back pointless biopsies, minimizing potential issues and affected person anxiousness related to the process. By figuring out these at greater danger, it permits for extra targeted and environment friendly use of assets, enhancing the general high quality of affected person care and doubtlessly resulting in earlier prognosis of clinically vital illness. The event of this check displays a rising pattern in direction of customized drugs, the place diagnostic instruments are tailor-made to particular person danger profiles.
